Cofactor Genomics

Cofactor Genomics

Life science pharmaceutical and drug development.

Human health & social work | United States of America | Disease Specific Prevention and Mitigation |

 

Overview

Cofactor Genomics uses RNA to diagnose disease. Their team of past Human Genome Project Scientists have created RNA based tests that are enabling drug companies to develop new drugs. Their tests will help physicians make personalized medicine a reality. They are providing valuable and unique diagnostics and disease monitoring for the 95% of diseases that can not be diagnosed by DNA. Cofactor s molecular detection technology allows us to detect specific RNAs 100X more sensitively than current methods and the result is they are detecting key molecules indicating disease. This molecular technology paired with Cofactor s Machine Learning based software is paving the way for new diagnostics that achieve the signal to noise separation necessary to make RNA based diagnostics a reality. They currently have the largest database of RNA profiles.

Industry

Legal Structure

Operating Status

Employees

Human health & social work Other Legal Structure Operating 11 - 50 employees

Funding and Financing Rounds


Team


Impact

Social Objectives:

Environmental Objectives:

Operational Impact:


Impact Reports & Metrics


Offices

Headquarters

188 King Street
San Francisco, California 94107
United States of America



Explore

Revision History

Last Update: Nov 30, 2017 5:29 p.m.

Quick Search



  • Global  
  • Africa  
  • Americas  
  • Asia  
  • Europe  
  • Oceania  


Incoming

Tags

COPYRIGHT 2017 IMPACTSPACE. ALL RIGHTS RESERVED.